Introduction
Hepatocellular Carcinoma (HCC) was rated as the sixth cancer
in the world [1,2], it has a high mortality rate [3-5]. The pathogenesis of HCC is mainly related to HBV or HCV infection. Hepatectomy is a surgical procedure that removes local lesions from the
liver to retain a normal function of the liver group, mainly for the
treatment of liver cancer and some benign liver diseases (such
as hepatic angiosarcoma, hepatic dysplastic nodules, hepatic leiomyoma) [4,6,7]. In the treatment of patients with liver cancer,
laparoscopic liver cancer resection is the earliest and most widely
used minimally invasive surgery [8,9]. However, it also has limitations such as two-dimensional surgical field, limited movement
of laparoscopic instruments, and inevitable physiological tremors
[3,10-12]. Robotic surgery technology helps surgeons overcome
the shortcomings of traditional laparoscopic surgery by providing
surgeons with high-resolution 3D images, wrist instruments that
provide degrees of freedom, and tremor filtering technology [13].
However, studies [14-16] found no significant difference between
the robotic surgery group and the laparoscopic group in terms of
transfusion rate, conversion rate, estimated blood loss, length of
hospital stay, and reoperation rate. In this case, which with lower
costs may be the best option. Cost-minimization identifies the
lowest cost of treatments that have been shown to be otherwise
equivalent in clinical effectiveness.
Therefore, we designed a cost-minimization analysis to explore
the cost difference of roboticassisted versus laparoscopic-assisted
liver cancer resection, so as to provide the valuable reference for
clinical practice and patients.
Methods
Study design: Cost-minimization analysis was designed to determine the most economical option for the medical technology
with the same efficacy and safety. Since the efficacy and safety of
robotic-assisted and laparoscopic liver cancer resection are comparable, this study aims to compare the costs of the two surgical
methods. The costs in economic evaluation include direct costs,
indirect costs and hidden costs. This study only compares the direct medical costs, including operation fee, medical materials fee,
adjuvant therapy fee, medicine fee, medical examination fee, anesthesia fee, health care fee, and hospitalization fee. All costs are
in 2022 RMB.
Data source
The purpose of this study is to reflect the situation in the real
world. We investigated liver cancer patients from Gansu Provincial People’s Hospital, including adult patients with robot assisted
liver cancer resection and patients with laparoscopic assisted liver
cancer resection.
Statistical analyses
This study uses excel 2016 software to collect and analyze cost
data. The analysis outcomes include the total costs of per patient undergoing robotic surgery and laparoscopic surgery, and the
average costs of per patient in each cost item, including operation fee, medical materials fee, adjuvant therapy fee, medicine
fee, medical examination fee, anesthesia fee, health care fee, and
hospitalization fee.
One-way deterministic sensitivity analysis was performed to
assess the uncertainty of the parameter values and gauge the reliability and generalizability of the results. The parameters included: cost of operation, cost of medical materials, cost of adjuvant
therapy, cost of medicine, cost of medical examination, cost of
anesthesia, cost of health care, and cost of hospitalization.
All parameters were subjected to ±10%, and assuming they
were all independent of each other.
Results
Fifty-one patients with liver cancer were selected from Gansu
Provincial People’s Hospital, including 18 patients with robot assisted hepatectomy and 33 patients with laparoscopic assisted
hepatectomy. The Cost-minimization analysis showed that the
average medical cost of per patient receiving robotic surgery was
60,322 yuan, and the average medical cost of per patient receiving laparoscopic surgery was 46,867 yuan. Compared with robotic
surgery, laparoscopic surgery could save 13,455 yuan. The operation fee, medical materials fee, other adjuvant therapy fee and
health care fee of robotic surgery are higher than those of laparoscopic surgery. However, the medicine fee, medical examination
fee, anesthesia fee and hospitalization fee of laparoscopic surgery
are slightly higher than those of robotic surgery. Among them, the
biggest difference is the ooperation fee, which is 16,915 yuan for
robotic surgery and 6467 yuan for laparoscopic surgery, the difference is 10,448 yuan. See Table 1 and Figure 1.
Table 1: Clinicopathological characteristics of PEACs in comparison with MCC.
Cost item |
Robotic hepatectomy (¥)
|
Laparoscopic hepatectomy (¥)
|
Cost (¥) |
Saving Proportion of cost
saving (%)
|
Operation |
16,915 |
6467 |
10,448 |
78% |
Medical materials |
13,524 |
11,842 |
1682 |
13% |
Adjuvant therapy |
9796 |
4959 |
4837 |
36% |
Medicine |
9244 |
10,718 |
-1474 |
-11% |
Medical examination |
7416 |
9090 |
-1674 |
-12% |
Anesthesia |
2046 |
2274 |
-228 |
-2% |
Health care |
842 |
802 |
40 |
0% |
Hospitalization |
539 |
715 |
-176 |
-1% |
Total cost |
60,322 |
46,867 |
13,455 |
100% |
Sensitivity analyses showed cost of robotic-assisted operation
and medical materials had a significant impact on the results (Figure 2).
Discussion
Since the introduction of the robotic surgery, there has been
a push to demonstrate the effectiveness and safety of roboticassisted over the conventional laparoscopic liver cancer resection
[17-19]. The Cost-minimization analysis showed that the average
medical cost of per patient receiving robotic surgery was higher
than receiving laparoscopic liver cancer resection. Compared with
robotic surgery, laparoscopic surgery could save 13,455 yuan. The
biggest difference is the operation fee, which is 16,915 yuan for
robotic surgery and 6467 yuan for laparoscopic surgery, the difference is 10,448 yuan.
Although this study indicated that robot-assisted liver cancer
resection maybe more expensive than laparoscopic liver cancer
resection, clinical clinicians and patients should consider more
factors when deciding whether to choose robotic assisted liver
cancer resection. Currently, an increasing number of studies have
investigated the clinical outcomes of robot-assisted liver cancer
resection versus laparoscopic and open liver cancer resection,
however, the evidence of cost analyses was lacking, and the results of the limited evidence was inconsistent. Wu et al analyzed
100 patients and indicated that the robotic group incurred higher
peri-operative expenses, while the cost of inpatient care was lower than open surgery group [7]. One study from USA indicated that
the operative cost was significantly higher in the robotic group,
while overall admission cost was comparable between robotic
and conventional open hepatectomy [20]. A meta-analysis including 29 studies (537 patients) indicated that the cost of the laparoscopic liver cancer resection was greater than robotic surgery, the
results was conflict with our results, it should be interpreted with
caution. Therefore, more research are needed to further analyze the costs of robot-assisted, laparoscopic, and open liver cancer
resection in the future.
Due to a number of technological advancements, including
greater visibility, increased angulation and range of motion, and
more precise suturing, robotic surgical systems are better than
laparoscopic devices [20-24]. Robotic surgical systems are now
employed in a wide range of operations and specialties, such as
head and neck surgery, urology, endocrine surgery, metabolic and
bariatric surgery, and all intra-abdominal surgery subspecialties
[25-27]. Additionally, the number of patients undergoing robotic
surgery is rising quickly. Because of limited evidence of the efficacy, safety, and economic evaluation of robotic assisted liver
cancer resection versus laparoscopic liver cancer resection, in the
future, more high-quality studies are needed to further explore
the advantages and disadvantages of robot-assisted liver cancer
resection versus laparoscopic liver cancer resection.
Limitations
There are several limitations of this study. On the one hand,
our data source are limited and only from one single hospital in
Lanzhou of China, a broader range of evidence is needed to support clinical practice in the future; On the other hand, this study
assumed that the efficacy of robot assisted liver cancer resection
and laparoscopic liver cancer resection were consistent, but the
efficacy and safety outcomes we analyzed were limited, some
long-term outcomes, such as overall survival, and incidence of adverse events, were not analyzed. Therefore, future studies in this
area are needed.
Conclusion
Limited data showed that the average medical cost of roboticassisted liver cancer resection was higher than laparoscopic liver
cancer resection. The difference is mainly due to the operation
fee. To further analyze the advantages and disadvantages of robotic-assisted and laparoscopic liver cancer resection, high-quality cost-effectiveness analysis is needed in the future.
Declarations
The authors declare no conflicts of interest.
No funding was received for writing this manuscript.
References
- Salloum C, et al. Robotic-assisted versus laparoscopic left lateral sectionectomy: Analysis of surgical outcomes and costs by a propensity score matched cohort study. World journal of surgery. 2017; 41: 516-524.
- Magistri P, et al. Robotic vs open distal pancreatectomy: A multi‐institutional matched comparison analysis. Journal of Hepato‐Biliary‐Pancreatic Sciences. 2021; 28: 098-1106.
- Wu YM, et al. Robotic-assisted minimally invasive liver resection. Asian J Surg. 2014; 37: 53-7.
- Wong DJ, et al. Systematic review and meta-analysis of robotic versus open hepatectomy. ANZ J Surg. 2019; 89: 165-170.
- Ziogas IA, et al. Laparoscopic versus robotic major hepatectomy: A systematic review and meta-analysis. 2021; 35: 524-535.
- Yan Y, Cai X, DA Geller. Laparoscopic Liver Resection: A Review of Current Status. J Laparoendosc Adv Surg Tech A. 2017; 27: 481-486.
- Wu CY, et al. Is robotic hepatectomy cost-effective? In view of patient-reported outcomes. Asian J Surg. 2019; 42: 543-550.
- Wang WH, et al. Oncological and surgical result of hepatoma after robot surgery. Surg Endosc. 2018; 32: 3918-3924.
- Wang H, et al. A historical review and bibliometric analysis of GPS research from 1991-2010. 2013; 95: 35-44.
- Troisi RI, et al. Robot assistance in liver surgery: A real advantage over a fully laparoscopic approach? Results of a comparative bi‐institutional analysis. The International Journal of Medical Robotics and Computer Assisted Surgery. 2013; 9: 160-166.
- Sucandy I, et al. Robotic hepatectomy for benign and malignant liver tumors. J Robot Surg. 2020; 14: 75-80.
- Spampinato MG, et al. Perioperative outcomes of laparoscopic and robot-assisted major hepatectomies: An Italian multi-institutional comparative study. Surg Endosc. 2014; 28: 2973-9.
- Prueksapanich P, et al. Liver Fluke-Associated Biliary Tract Cancer. 2018; 12: 236 - 245.
- Salloum C, et al. Robotic-Assisted Versus Laparoscopic Left Lateral Sectionectomy: Analysis of Surgical Outcomes and Costs by a Propensity Score Matched Cohort Study. World J Surg. 2017; 41: 516-524.
- Thun MJ, et al. Lung cancer. 2018: 519-542.
- Tsung A, et al. Robotic versus laparoscopic hepatectomy: A matched comparison. Ann Surg. 2014; 259: 549-55.
- Liu R, et al. International consensus statement on robotic hepatectomy surgery in 2018. World J Gastroenterol. 2019; 25: 1432-1444.
- Lim C, et al. Short- and Long-term Outcomes after Robotic and Laparoscopic Liver Resection for Malignancies: A Propensity ScoreMatched Study. World J Surg. 2019; 43: 1594-1603.
- Leung U, Y Fong. Robotic liver surgery. Hepatobiliary Surgery and Nutrition. 2014; 3: 288-294.
- Hawksworth J, et al. Robotic Hepatectomy Is a Safe and Cost-Effective Alternative to Conventional Open Hepatectomy: a Single-Center Preliminary Experience. J Gastrointest Surg. 2021; 25: 825-828.
- Lai ECH, et al. Robotic hepatectomy for hepatocellular carcinoma: A clinical review % J Hepatoma Research. 2017; 3.
- Kingham TP, et al. Robotic Liver Resection: A Case-Matched Comparison. World J Surg. 2016; 40: 1422-8.
- Kang CM, et al. The first Korean experience of telemanipulative robot-assisted laparoscopic cholecystectomy using the da Vinci system. Yonsei medical journal. 2007; 48: 540-545.
- Gavriilidis P, et al. A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network metaanalysis. Eur J Surg Oncol. 2020; 46: 1214-1224.
- Lee SJ, et al. The feasibility of robotic left-side hepatectomy with comparison of laparoscopic and open approach: Consecutive series of single surgeon. Int J Med Robot. 2019; 15: e1982.
- Lee KF, et al. Robotic Liver Resection For Primary Hepatolithiasis: Is It Beneficial? World J Surg. 2016; 40: 2490-6.
- Lee KF, et al. Robotic versus open hemihepatectomy: a propensity score-matched study. Surg Endosc. 2021; 35: 2316-2323.